Associate Professor, Surgical Oncology
Huntsman Cancer Institute, University of Utah Health
Salt Lake City, Utah, United States
Dr. John Hyngstrom is an Associate Professor in the section of Surgical Oncology, division of General Surgery within the department of Surgery at the University of Utah. His medical practice at the Huntsman Cancer Institute is in general surgical oncology with a focus on melanoma and other cutaneous malignancies as well as soft tissue sarcoma. His research interests include immunotherapy clinical trial development and survivorship issues in cancer patients. He currently serves as the site primary investigator at HCI on multiple therapeutic cooperative group and industry sponsored clinical trials focusing on improving care for patients with advanced melanoma and other solid tumors. He is director of the physician-lead Clinical Trials Research Group and the clinical lead of the Melanoma Disease Center at HCI. He also serves as the Surgery Chair of the Melanoma Working Group of the Southwest Oncology Cooperative Group through the NCI.
Dr. Hyngstrom earned his Bachelor of Arts degree from Washington University in St. Louis, Missouri. He earned his Doctor of Medicine from the University of Chicago Pritzker School of Medicine and completed his general surgery residency at the University of Chicago Medical Center. During his residency, he completed a two-year clinical research fellowship in surgical oncology and tumor immunology at the Surgery Branch of the NCI/NIH in Bethesda, Maryland. After finishing his general surgery training, Dr. Hyngstrom obtained his fellowship training in general surgical oncology at the University of Texas MD Anderson Cancer Center.
Bristol Myers Squibb (Individual(s) Involved: Self): Consultant; Nektar Therapeutics (Individual(s) Involved: Self): Advisor or Review Panel member
Thursday, March 10, 2022
3:00 PM – 3:30 PM CST
Thursday, March 10, 2022
3:01 PM – 3:08 PM CST
Saturday, March 12, 2022
9:42 AM – 10:00 AM CST
Saturday, March 12, 2022
10:00 AM – 10:10 AM CST